Compounds, compositions and methods for the treatment of tauopathies
CN104010641A
Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies
WO2012118935A1
Compounds for the treatment of neurodegenerative diseases
US2010179223A1
Compounds, compositions, and methods for the treatment of synucleinopathies
BRPI0920687A2
A compound, pharmaceutical composition, and methods for inhibiting the formation, deposition, accumulation, or persistence of amyloid abeta or alpha-synuclein aggregates, to treat a beta-amyloid disease or synucleinopathy in a suffering mammal, to improve performance. in a mammal suffering from a synucleinopathy, and to halt the progression of motor deficits in a mammal suffering from parkinson's disease
WO2009111611A2
Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes
US2009253637A1
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein disorders
WO2008097692A1
Compounds, compositions and methods for the treatment of inflammatory diseases
US2007225362A1
Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
MXPA06012603A
Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies.
ZA200610028B
Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
WO2005060683A2
Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders
AU2003286845A1
Amyloid plaque formation by glycosaminoglycans
EP1921076A1
systhesis of procyanidin B2
US7514583B2
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
US7205008B2
Methods of treating Alzheimer's disease and other amyloidoses using Hypericum perforatum and derivatives thereof
NZ528321A
Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
EP1377287A2
Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
WO0241842A2
Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
NZ544691A
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
